Primary Aldosteronism: Prospective Screening Registry in China
Recruiting
Observational Study
Primary Aldosteronism
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
1. Study name: A prospective study of the incidence and outcomes of Primary aldosteronism in Chinese hypertensive patients
2. Rationale: Unlike essential hypertension, secondary hypertension is caused by certain defined diseases or causes. For this reason, secondary hypertension can often be cured or effectively controlled. As one of the most common types of secondary hypertension, it is estimated…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Eligibility criteria
1. Age: more than or equal to 18 years old;
2. Hypertensive patients ;
3. ARR \> 40;
4. Informed consent;
Exclusion criteria:
Not eligible for inclusion or in situations considered unqualified for the study by the investigator.
Contacts